168 related articles for article (PubMed ID: 6304479)
1. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
Takada K; Fujiwara S; Yano S; Osato T
Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
Lin JC; Choi EI; Pagano JS
J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
[TBL] [Abstract][Full Text] [Related]
4. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.
Sanchez-Pinel A; Bernad J; Rives H; Icart J; Didier J
Res Virol; 1989; 140(6):531-43. PubMed ID: 2559442
[TBL] [Abstract][Full Text] [Related]
6. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
7. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
Tsai CH; Glaser R
Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
Thorley-Lawson DA; Geilinger K
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
[TBL] [Abstract][Full Text] [Related]
10. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
12. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
Qualtiere LF; Chase R; Vroman B; Pearson GR
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
Hoffman GJ; Lazarowitz SG; Hayward SD
Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies.
Dölken G; Hecht T; Röckel D; Hirsch FW
Virology; 1987 Apr; 157(2):460-71. PubMed ID: 3029983
[TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies to Epstein-Barr virus capsid antigen by immune adherence hemagglutination.
Lennette ET; Ward E; Henle G; Henle W
J Clin Microbiol; 1982 Jan; 15(1):69-73. PubMed ID: 6313742
[TBL] [Abstract][Full Text] [Related]
16. A novel early antigen associated with Epstein-Barr virus productive cycle.
Freemer CS; Bertoni G; Takagi S; Sairenji T
Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
[TBL] [Abstract][Full Text] [Related]
17. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
Fujiwara S; Takada K; Yano S; Osato T
Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
[TBL] [Abstract][Full Text] [Related]
18. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.
Pearson GR; Vroman B; Chase B; Sculley T; Hummel M; Kieff E
J Virol; 1983 Jul; 47(1):193-201. PubMed ID: 6306272
[TBL] [Abstract][Full Text] [Related]
19. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
Tsai CH; Williams MV; Glaser R
Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
